ENRILONG
Live / Applied — Withdrawn from registration (as of 26 Apr 2024)
What this means for you
Not registered yet, but its 24 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97811501
- Mark type
- Word mark
- Filed
- 24 Feb 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; Medicinal preparations for the prevention and treatment of tumors; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Antiviral drugs for medical purposes; Crude drugs in the nature of pharmaceutical preparations for the treatment of immune system related diseases and disorders; Gelatin capsules sold empty for pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for tumors; Injectable pharmaceuticals for treatment of cancer; Biological preparations for the treatment of cancer
Owner
- 3D Medicines (Beijing) Co., Ltd., Beijing, CN
- 3D Medicines (Beijing) Co., Ltd., Beijing, CN
Prosecution history
- 27 Jun 2024 — WITHDRAWAL OF ATTORNEY GRANTED
- 27 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 26 Apr 2024 — WITHDRAWN FROM ISSUE - COMM.OFFICE REQUEST
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION
- 21 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Feb 2024 — ELECTRONIC RECORD REVIEW COMPLETE
- 19 Jan 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 15 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jan 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 08 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED